Close Menu

NEW YORK – Roche said today that it is expanding its Global Access Program to include tests for tuberculosis, hepatitis B and C, and human papillomavirus in programs for low- and middle-income countries where the disease burden is the highest.

"With effective treatment options for these infectious agents and improved patient access to diagnostics, early detection can help save lives and ease suffering," Roche Diagnostics CEO Michael Heuer said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.